Activist Investing Today: Coast's Rasteh on FirstGroup, Covid-19
The founder of the New York-based activist fund explains why he hires CEO experts and other advisers to assist with the fund's campaigns. He also explains why he will stick with his investment and cam...
23 Mars 202020min
Activist Investing Today: V&E's Elbaum on Covid-19 vs. 2008
Many hedge funds first-time activists, family offices and private equity funds who have been contemplating activism are going to walk away from their campaigns, while established activist investors su...
13 Mars 202025min
Drinks With The Deal: Steven Lipin of Gladstone Place Partners
Steven Lipin, founder of communications firm Gladstone Place Partners, talks with The Deal’s David Marcus about the Anixter and Disney/Fox deals, the lessons of WeWork, how he’s gone about building hi...
6 Mars 202029min
Activist Investing Today: Author Geoffrey Cain
Geoffrey Cain, author of a "Samsung Rising," talked with The Deal for its Activist Investing Today Podcast, about chaebols, the biggest swing vote in South Korea and activist investing. Cain provided ...
5 Mars 202029min
Activist Investing Today: Banking Insurgent on M&A, Majority Votes
New community banking activist Abbott Cooper offers his thoughts on his M&A pushes at Community Bankers Trust and First United, two middle-market financial institutions. In a wide ranging conversation...
10 Feb 202033min
Drinks With The Deal: Ted Smith of Union Square Advisors
Ted Smith, president of Union Square Advisors, discusses Permira's purchase of a majority stake in Lytx, the rise of tech PE, the outlook for software M&A, his work in building Union Square and his lo...
7 Feb 202028min
Activist Investing Today: Hamermesh on Icahn, Bylaws and Insider Votes
Widener University's Lawrence Hamermesh talks about why there isn't much clarity about whether activists can gain access to corporate books and records to help director fights. The corporate governanc...
28 Jan 202020min
Drinks With The Deal: Sullivan & Cromwell’s Frank Aquila
Frank Aquila discusses his work for Tiffany’s on its sale to LVMH, for AmGen on its purchase of Otezla, and for Novartis on its billion purchase of Medicines Co. as well as his favorite spots in New Y...
10 Jan 202029min
